(Q71784852)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7577385%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Hybrid (COPP/ABV) therapy in childhood Hodgkin's disease: a study of 53 cases during 1989-1993 at the Cancer Institute, Madras (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7577385%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Hybrid (COPP/ABV) Therapy in Childhood Hodgkin's Disease: A Study of 53 Cases During 1989–1993 at the Cancer Institute, Madras (English)

1 reference

https://api.crossref.org/works/10.3109/08880019509029583

19 May 2024

author name string

P. V. Sripada

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577385

19 May 2024

S. G. Tenali

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577385

19 May 2024

M. Vasudevan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577385

19 May 2024

S. Viswanadhan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577385

19 May 2024

D. Sriraman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577385

19 May 2024

R. Kandasamy

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577385

19 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7577385

19 May 2024

publication date

1 July 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7577385%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

21 October 2019

http://www.tandfonline.com/doi/pdf/10.3109/08880019509029583

1 reference

https://api.crossref.org/works/10.3109/08880019509029583

Pediatric Hematology and Oncology

19 May 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7577385%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7577385%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7577385%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

333-341

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7577385%20AND%20SRC:MED&resulttype=core&format=json

Pediatric hodgkin's disease. II. Results of therapy

21 October 2019

cites work

2

1 reference

https://api.crossref.org/works/10.3109/08880019509029583

Childhood Hodgkin's disease in Uganda: a ten year experience

19 May 2024

3

1 reference

https://api.crossref.org/works/10.3109/08880019509029583

Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease

19 May 2024

5

1 reference

https://api.crossref.org/works/10.3109/08880019509029583

Treatment with MOPP or ChlVPP chemotherapy only for all stages of childhood Hodgkin's disease

19 May 2024

9

1 reference

https://api.crossref.org/works/10.3109/08880019509029583

Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology

19 May 2024

12

1 reference

https://api.crossref.org/works/10.3109/08880019509029583

19 May 2024

14

26

1311

Lukes R J

1966

1 reference

https://api.crossref.org/works/10.3109/08880019509029583

19 May 2024

15

31

1860

Carbone P P

1971

1 reference

https://api.crossref.org/works/10.3109/08880019509029583

Nonparametric Estimation from Incomplete Observations

19 May 2024

16

1 reference

https://api.crossref.org/works/10.3109/08880019509029583

Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease

19 May 2024

21

1 reference

https://api.crossref.org/works/10.3109/08880019509029583

A decade of combination chemotherapy of advanced Hodgkin's disease

19 May 2024

22

1 reference

https://api.crossref.org/works/10.3109/08880019509029583

Hodgkin's disease in children

19 May 2024

23

1 reference

https://api.crossref.org/works/10.3109/08880019509029583

Results of treatment of 18 children with Hodgkin disease with MOPP chemotherapy as the only treatment modality

19 May 2024

24

1 reference

https://api.crossref.org/works/10.3109/08880019509029583

Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results.

19 May 2024

29

1 reference

https://api.crossref.org/works/10.3109/08880019509029583

BCVPP chemotherapy for advanced Hodgkin's disease: evidence for greater duration of complete remission, greater survival, and less toxicity than with a MOPP regimen. Results of the Eastern Cooperative Oncology Group study

19 May 2024

30

1 reference

https://api.crossref.org/works/10.3109/08880019509029583

Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD

19 May 2024

32

1 reference

https://api.crossref.org/works/10.3109/08880019509029583

Efficacy and toxicity of 12 courses of ABVD chemotherapy followed by low-dose regional radiation in advanced Hodgkin's disease in children: a report from the Children's Cancer Study Group

19 May 2024

35

1 reference

https://api.crossref.org/works/10.3109/08880019509029583

An evaluation of long-term survival and treatment complications in children with Hodgkin's disease

19 May 2024

37

1 reference

https://api.crossref.org/works/10.3109/08880019509029583

Long-term results of treatment of children and adolescents with Hodgkin's disease

19 May 2024

38

1 reference

https://api.crossref.org/works/10.3109/08880019509029583

Thyroid Diseases after Treatment of Hodgkin's Disease

19 May 2024

41

1 reference

https://api.crossref.org/works/10.3109/08880019509029583

MOPP chemotherapy versus extended-field radiotherapy in the management of pathological stages I-IIA Hodgkin's disease

19 May 2024

42

1 reference

https://api.crossref.org/works/10.3109/08880019509029583

Septicemia and meningitis in children splenectomized for hodgkin's disease

19 May 2024

43

1 reference

https://api.crossref.org/works/10.3109/08880019509029583

Advances in the treatment of Hodgkin's disease

19 May 2024

45

1 reference

https://api.crossref.org/works/10.3109/08880019509029583

Gonadal function in pediatric patients following treatment for Hodgkin disease

19 May 2024

46

1 reference

https://api.crossref.org/works/10.3109/08880019509029583

Testicular dysfunction in Hodgkin's disease before and after treatment

19 May 2024

48

1 reference

https://api.crossref.org/works/10.3109/08880019509029583

19 May 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7577385%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference